β1-Blocker improves survival and ventricular remodelling in rats with lethal crush injury
- PMID: 32488449
- DOI: 10.1007/s00068-020-01408-y
β1-Blocker improves survival and ventricular remodelling in rats with lethal crush injury
Abstract
Background: Crush injury/crush syndrome (CI/CS) is the second most common cause of death during earthquakes. Most studies of CI/CS have mainly focused on kidney injury after decompression. Few studies have focused on myocardial injury caused by crush injury and its potential mechanisms.
Methods: We first verified cardiomyocyte injury during compression in rats with a crush injury. The survival rate, electrocardiographic results, histological results, catecholamine changes and cardiac β1-AR expression were evaluated. Next, we explored the effects of pretreatment with a selective β1-blocker (bisoprolol) with or without fluid resuscitation on rats with a crush injury. In addition to evaluating the survival rates, biochemical and histological analyses and echocardiographic measurements were also performed.
Results: Reduced heart rates, elevated ST segments, and tall-peaked T waves were observed in the rats with a crush injury. The changes in the myocardial enzymes and pathological results demonstrated that myocardial damage occurred during compression in rats with a crush injury. The levels of the catecholamine norepinephrine in both the serum and myocardial tissue were elevated during compression. Pretreatment with a selective β1-blocker combined with fluid resuscitation significantly improved the survival rates of the rats with lethal crush injury. The myocardial enzymes and pathological results showed that the combined therapy decreased myocardial damage. The echocardiography measurements showed that the rats that received the combined therapy exhibited decreased left ventricular mass (LVM), left ventricular volume at end-systole (LVVs) and left ventricular internal diameter (LVID) compared with the rats with a crush injury.
Conclusions: Our findings demonstrated the presence of myocardial injury in the early stage of compression in rats with a crush injury. Pretreatment with a β1-blocker (bisoprolol) with fluid resuscitation significantly reduced mortality, decreased myocardial tissue damage, and improved ventricular remodelling in rats with a lethal crush injury.
Keywords: Beta-adrenergic receptors; Crush injury; Myocardial injury; Ventricular remodelling; β-Blocker.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Impact of traumatic muscle crush injury as a cause of cardiomyocyte-specific injury: an experimental study.Heart Lung Circ. 2013 Apr;22(4):284-90. doi: 10.1016/j.hlc.2012.11.008. Epub 2012 Dec 14. Heart Lung Circ. 2013. PMID: 23246461
-
Electrocardiographic changes after injury in a rat model of combined crush injury.Am J Emerg Med. 2013 Dec;31(12):1661-5. doi: 10.1016/j.ajem.2013.08.054. Epub 2013 Oct 4. Am J Emerg Med. 2013. PMID: 24094864
-
[Experimental study on establishment of a simple model of rats crush injury-crush syndrome].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Jan;27(1):77-82. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013. PMID: 23427499 Chinese.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
-
Emerging medical therapies in crush syndrome - progress report from basic sciences and potential future avenues.Ren Fail. 2020 Nov;42(1):656-666. doi: 10.1080/0886022X.2020.1792928. Ren Fail. 2020. PMID: 32662306 Free PMC article. Review.
Cited by
-
Cardiovascular events in crush syndrome: on-site therapeutic strategies and pharmacological investigations.Front Pharmacol. 2024 Sep 20;15:1472971. doi: 10.3389/fphar.2024.1472971. eCollection 2024. Front Pharmacol. 2024. PMID: 39372200 Free PMC article. Review.
References
-
- Speck K, Schneider BS, Deashinta N. A rodent model to advance the field treatment of crush muscle injury during earthquakes and other natural disasters. Biol Res Nurs. 2013;15(1):17–25. https://doi.org/10.1177/1099800411414698 . - DOI - PubMed - PMC
-
- Sever MS, Vanholder R. Crush syndrome: a case report and review of the literature. J Emerg Med. 2015;48(6):730–1. https://doi.org/10.1016/j.jemermed.2014.07.063 . - DOI - PubMed - PMC
-
- Sever MS, Vanholder R. Management of crush syndrome casualties after disasters. Rambam Maimonides Med J. 2011;2(2):e0039. https://doi.org/10.5041/RMMJ.10039 . - DOI - PubMed - PMC
-
- Zhang BF, Wang PF, Cong YX, Lei JL, Wang H, Huang H, et al. Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-alpha and c-Jun N-terminal kinase pathway. J Orthop Surg Res. 2017;12(1):110. https://doi.org/10.1186/s13018-017-0614-z . - DOI - PubMed - PMC
-
- Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135. https://doi.org/10.1186/s13054-016-1314-5 . - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials